Medical news update
- Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction
This randomized clinical trial examines follow-up data for older patients with myocardial infarction to determine the benefits of physiology-guided complete revascularization of nonculprit lesions vs […]
- JAMA Cardiology
Mission Statement: JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, […]
- WHO STEPS and the Future of Cardiovascular Disease Prevention
By the early 2000s, noncommunicable diseases (NCDs) had become the dominant global health threat, yet most countries lacked even the most basic data to guide prevention. In response, the World Health […]
- Blood Pressure and Microaxial Flow Pump Patient Selection
Cardiogenic shock complicates 5% to 10% of acute myocardial infarction (AMI) cases and is associated with substantial in-hospital mortality. The 1999 Should We Emergently Revascularize Occluded […]
- Clonal Hematopoiesis—Fuel to Inflame the Heart
Clonal hematopoiesis, often referred to as clonal hematopoiesis of indeterminate potential (CHIP), has emerged as an important and independent risk factor for cardiovascular disease. It arises from […]
- Evidence About Benefits and Risks of Vaccines
In this issue of JAMA Cardiology, Johansen and colleagues report findings from a prespecified secondary analysis of the DANFLU-2 pragmatic randomized clinical trial comparing the efficacy of […]
- Pathway to Risk Stratification in Tricuspid Regurgitation—Reply
In Reply Assessment of tricuspid regurgitation (TR) is complex and requires comprehensive evaluation of multiple echocardiographic views and parameters. These considerations also need to be balanced […]
- Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function
This secondary analysis of the AZALEA-TIMI 71 randomized clinical trial examines the safety of abelacimab vs rivaroxaban across a range of kidney function.
- Ethnicity and sub-Saharan African representation in the emergency development of covid-19 vaccines
- Ethnicity and sub-Saharan African representation in the emergency development of covid-19 vaccines
- Household size and its role in the association between multimorbidity and health and social care outcomes in older adults in Wales: retrospective cohort study
- Reproducibility of meta-analytic results in systematic reviews of interventions: meta-research study
- Household size and its role in the association between multimorbidity and health and social care outcomes in older adults in Wales: retrospective cohort study
- Reproducibility of meta-analytic results in systematic reviews of interventions: meta-research study
- Trends in hypertension prevalence, control, and antihypertensive use in England from 2003 to 2021: insights from annual, nationwide Health Surveys for England
- Trends in hypertension prevalence, control, and antihypertensive use in England from 2003 to 2021: insights from annual, nationwide Health Surveys for England
- Challenges in evaluating whole genome sequencing for newborn screening: series of systematic reviews and roadmap for evidence generation for policy advisers
- Challenges in evaluating whole genome sequencing for newborn screening: series of systematic reviews and roadmap for evidence generation for policy advisers
- The spleen: a novel player in human blood pressure regulation
No abstract available
- Arterial hypertension–attributable mortality in Europe: implications for the Americas
No abstract available
- Ventricular–arterial coupling is preserved in prematurely born 11-year-old children but calls for life-long prevention of hemodynamic deterioration
No abstract available
- Reply to correspondence ‘Gut microbiome–metabolome interplay in nondipper hypertension: pathophysiological insights and clinical perspectives’
No abstract available
- Gut microbiome–metabolome interplay in nondipper hypertension: pathophysiological insights and clinical perspectives
No abstract available
- Potassium-enriched salt for patients with hypertension: a Hypertension Australia and National Hypertension Taskforce of Australia Position Statement
Introduction: High blood pressure remains the leading risk factor for cardiovascular and all-cause deaths in Australia. Higher sodium and lower potassium intake are well established risk factors […]
- Relation of carotid-to-femoral pulse wave velocity to aortic stiffness and total arterial compliance in healthy individuals
Background: Carotid-to-femoral pulse wave velocity (c-f PWV) is commonly used to assess large artery stiffness, particularly as a surrogate of aortic stiffness. Given that c-f PWV represents the […]
- Target trial emulation in hypertension research: a scoping review of current applications and methodological practices
Target trial emulation (TTE) is a demanding framework for causal inference using observational data, yet its use in hypertension research is limited. This scoping review maps current TTE […]
- ESH Hybrid Webinar 2025
Date: Thursday, 4 December 2025 Time: 17:00 (CET)
- ESH Webinars
First Webinar Date: Tuesday, 2 December 2025 Time: 12:30 – 13:30 CET 17:00 – 18:00 CET (Two time slots – same content) REGISTER NOW!
- JHTA – 45e Journées de l’Hypertension Arterielle
JHTA 2025 will take place in Marseille, 10–11 December 2025.
- ESH 2026
INNOVATIONS IN CARDIOMETABOLIC MANAGEMENT January 16 - Abstract Submission Final Deadline (NO DEADLINE EXTENSION) February 16 - Late Breaker Submission Opens February 27 - Late Breaker […]
- ESH MASTERplan for Hypertension Management in CKD – webinars
Did you miss the webinar “ESH MASTERplan for Hypertension Management in CKD”? The recording is now available HERE
- Summer School 2026
Date: 6-11 September, 2026 Venue: Lunteren, The Netherlands
- ESH 2024 webinars
Webinar 1: Key Points of the Hypertension Guidelines - The ESH MASTERplan for hypertension Webinar 2: Managing Hypertensive Patients in Clinical Practice – Update on the management of […]
- ESH Webinars 2024
PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies PART 2: Hypertension treatment challenges and options in comorbidities
- Issue Information
The Journal of Clinical Hypertension, Volume 27, Issue 12, December 2025.
- Relationship Between the Systemic Immune‐Inflammation Index and Non‐Dipper Blood Pressure Status in Normotensive Patients With Prediabetes
The Journal of Clinical Hypertension, Volume 27, Issue 12, December 2025.
- A Machine Learning–Based Model to Estimate the Risk of Pulmonary Hypertension in Chronic Kidney Disease Patients
The Journal of Clinical Hypertension, Volume 27, Issue 12, December 2025.
- Ambulatory Arterial Stiffness Index: Regression Method Comparison and Its Association With Pulse Pressure and Circadian Patterns
The Journal of Clinical Hypertension, Volume 27, Issue 12, December 2025.
- Clinical relevance of double‐arm blood pressure measurement and prevalence of clinically important inter‐arm blood pressure differences in Indian Primary Care
The Journal of Clinical Hypertension, Accepted Article.
- Trends and risk factors of hypertension in US Children and Adolescents, 1999–2023
Journal of Human Hypertension, Published online: 05 December 2025; doi:10.1038/s41371-025-01102-9Trends and risk factors of hypertension in US Children and Adolescents, 1999–2023
- Sodium reduction is the key ingredient in dietary treatment of hypertension – a randomized controlled trial on sodium, potassium and nitrate
Journal of Human Hypertension, Published online: 04 December 2025; doi:10.1038/s41371-025-01104-7Sodium reduction is the key ingredient in dietary treatment of hypertension – a randomized […]
- Prevalence of apparent treatment-resistant hypertension and screening rates for primary aldosteronism in an asian ambulatory care setting
Journal of Human Hypertension, Published online: 04 December 2025; doi:10.1038/s41371-025-01105-6Prevalence of apparent treatment-resistant hypertension and screening rates for primary aldosteronism […]
- Isolated nocturnal hypertension and its association with sleep duration and quality
Journal of Human Hypertension, Published online: 02 December 2025; doi:10.1038/s41371-025-01099-1Isolated nocturnal hypertension and its association with sleep duration and quality
- Hypertension disparities among non-hispanic black adults
Journal of Human Hypertension, Published online: 02 December 2025; doi:10.1038/s41371-025-01106-5Hypertension (HTN) is a major risk factor for cardiovascular disease, stroke, and increased mortality, […]
- Deviations in the diagnostic and management approach of hypertensive urgencies and emergencies in routine clinical practice as compared to the guidelines: a survey of physicians in tertiary hospitals
Journal of Human Hypertension, Published online: 28 November 2025; doi:10.1038/s41371-025-01101-wDeviations in the diagnostic and management approach of hypertensive urgencies and emergencies in […]
- Knowledge, attitudes, and behaviours related to reduced-sodium salt: a systematic review
Journal of Human Hypertension, Published online: 27 November 2025; doi:10.1038/s41371-025-01098-2Knowledge, attitudes, and behaviours related to reduced-sodium salt: a systematic review
- Hypertension in Chinese children: prevalence, phenotypes, stages, and associations with healthy lifestyles from a multi-visit study
Journal of Human Hypertension, Published online: 25 November 2025; doi:10.1038/s41371-025-01096-4Hypertension in Chinese children: prevalence, phenotypes, stages, and associations with healthy […]
- Revascularization for Asymptomatic Carotid Stenosis — The CREST-2 Study
In this landmark randomized trial, stenting was associated with fewer nondisabling strokes at 4 years.
- Acute Conversion of Atrial Fibrillation in the Emergency Department
Vernakalant beats procainamide for rapid conversion of patients with atrial fibrillation.
- Percutaneous vs. Surgical Aortic Valve Replacement: 7-Year Outcomes
Even patients at low surgical risk may reap the benefits of a less-invasive approach to aortic valve repair.
- Should We Continue Anticoagulation Indefinitely after Catheter Ablation of Atrial Fibrillation?
Another trial indicates that it isn't necessary in most patients.
- More Good News about PCSK9 Inhibitors
In the VESALIUS-VC trial, the PCSK9 inhibitor evolocumab reduced cardiovascular events in very-high-risk patients without prior MI or stroke.
- Does Coffee Really Worsen Atrial Fibrillation?
Conventional thinking has it wrong according to a randomized trial.
- How to Detect and When to Treat Nonculprit Coronary Lesions in STEMI?
Immediate invasive assessment of nonculprit lesions was no better than delayed stress MRI for guiding additional stenting in multivessel disease.
- Aggressive Lifestyle Management After Ablation for Atrial Fibrillation
In a randomized trial, a dedicated lifestyle clinic improved patients' risk factors and lowered recurrence of atrial fibrillation.